Prognostic Implication of Plasma Metabolites in Gastric Cancer
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Gastric cancer (GC) typically carries a poor prognosis as it is often diagnosed at a late stage. Altered metabolism has been found to impact cancer outcomes and affect patients’ quality of life, and the role of metabolites in gastric cancer prognosis has not been sufficiently understood. We aimed to establish a prognostic prediction model for GC patients based on a metabolism-associated signature and identify the unique role of metabolites in the prognosis of GC. Thus, we conducted untargeted metabolomics to detect the plasma metabolites of 218 patients with gastric adenocarcinoma and explored the metabolites related to the survival of patients with gastric cancer. Firstly, we divided patients into two groups based on the cutoff value of the abundance of each of the 60 metabolites and compared the differences using Kaplan–Meier (K-M) survival analysis. As a result, 23 metabolites associated with gastric cancer survival were identified. To establish a risk score model, we performed LASSO regression and Cox regression analysis on the 60 metabolites and identified 8 metabolites as an independent prognostic factor. Furthermore, a nomogram incorporating clinical parameters and the metabolic signature was constructed to help individualize outcome predictions. The results of the ROC curve and nomogram plot showed good predictive performance of metabolic risk features. Finally, we performed pathway analysis on the 24 metabolites identified in the two parts, and the results indicated that purine metabolism and arachidonic acid metabolism play important roles in gastric cancer prognosis. Our study highlights the important role of metabolites in the progression of gastric cancer and newly identified metabolites could be potential biomarkers or therapeutic targets for gastric cancer patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Eight metabolites (ornithine, phenyl acetyl-L-glutamine, porphobilinogen, linoleic acid, DL-dipalmitoyl phosphatidylcholine, 5′-mdthylthioadenosine, inosine triphosphate, and paraxanthine) were indicated as an independent prognostic factor of GC by the forest plot of the Cox regression analysis.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A study screening GC survival-associated metabolites identified 24 metabolites by using Kaplan–Meier survival analysis [58].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Enrichment analysis found that purine metabolism and linoleic acid metabolism were found to be the most significant metabolic pathways related to the survival of patients with GC.”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, E. C., Nilsson, M., Grabsch, H. I., van Grieken, N. C., & Lordick, F. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31288-5 · Cited by 4,803 · cited 2×
“Gastric cancer (GC) is one of the most prevalent causes of cancer-related deaths worldwide [1].”
BackgroundPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“SM(d18:1/16:0), DL-dipalmitoylphosphatidylcholine, and Cer(d18:0/12:0) all belong to sphingolipids [28].”
BackgroundThe Human Serum Metabolome (HUSERMET) Consortium, Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., Brown, M., Knowles, J. D., Halsall, A., et al. (2011) · Nature Protocols · doi:10.1038/nprot.2011.335 · Cited by 3,294
How To Build and Interpret a Nomogram for Cancer Prognosis
Iasonos, A., Schrag, D., Raj, G. V., & Panageas, K. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.9791 · Cited by 3,222 · cited 1×
“Owing to their intuitive visual presentation and personalized application, nomograms have become a popular tool for oncology prognosis [7,21].”
MethodImmune checkpoint targeting in cancer therapy: toward combination strategies with curative potential
Sharma, P., & Allison, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.03.030 · Cited by 2,345 · cited 1×
“Targeted programmed cell death-ligand 1(PD-L1) can promote lipid uptake by Trm cells, increase their survival rate, improve patient outcomes, and have promoted the mode transformation of cancer treatment [15].”
BackgroundUnderstanding the Intersections between Metabolism and Cancer Biology
Vander Heiden, M. G., & DeBerardinis, R. J. (2017) · Cell · doi:10.1016/j.cell.2016.12.039 · Cited by 2,293 · cited 1×
“The blocking of these pathways or restoration of altered metabolic pathways has been proven to be promising therapeutic target strategies [7,8].”
BackgroundCancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824 · cited 1×
“There is growing evidence that reprogrammed cellular metabolism supports tumorigenesis, progression, metastasis, and drug resistance [5,6].”
BackgroundGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
The multifaceted roles of fatty acid synthesis in cancer
Röhrig, F., & Schulze, A. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.89 · Cited by 1,651 · cited 1×
“A variety of lipid metabolites in tumor cells can also be targeted for cancer therapy [24].”
BackgroundSphingolipid metabolism in cancer signalling and therapy
Ogretmen, B. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.96 · Cited by 1,207
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189 · cited 2×
“In recent years, targeting cancer metabolism with precision has been considered highly effective in the clinic [19].”
BackgroundMetabolomics in cancer research and emerging applications in clinical oncology
Schmidt, D. R., Patel, R., Kirsch, D. G., Lewis, C. A., Vander Heiden, M. G., & Locasale, J. W. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21670 · Cited by 648 · cited 1×
“It provides valuable information on the metabolic profile of specific tumors and identifies key biomarkers for cancer diagnosis and prognosis [9,10].”
BackgroundInhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
Jones, C. L., Stevens, B. M., D'Alessandro, A., Reisz, J. A., Culp-Hill, R., Nemkov, T., Pei, S., Khan, N., Adane, B., Ye, H., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.10.005 · Cited by 585 · cited 1×
“Bioinformatics analysis can associate metabolites and their corresponding biological functions to understand cancer development and treatment through metabolomics application in cancer metabolic reprogramming [49,50].”
BackgroundExtracellular purines, purinergic receptors and tumor growth
Di Virgilio, F., & Adinolfi, E. (2017) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 559 · cited 1×
“Dysregulation of purine metabolism is closely associated with cancer development, making it a potential therapeutic target [51].”
BackgroundIL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression
Sadik, A., Somarribas Patterson, L. F., Öztürk, S., Mohapatra, S. R., Panitz, V., Secker, P. F., Pfänder, P., Loth, S., Salem, H., Prentzell, M. T., et al. (2020) · Cell · doi:10.1016/j.cell.2020.07.038 · Cited by 559 · cited 1×
“cancer cell motility and impair the anti-tumor response of the immune system, and it is an important mechanism used by cancer to evade immune surveillance [43,44].”
BackgroundCancer Metabolism: Phenotype, Signaling and Therapeutic Targets
Park, J. H., Pyun, W. Y., & Park, H. W. (2020) · Cells · doi:10.3390/cells9102308 · Cited by 548 · cited 1×
“Metabolomics can support research into predicting metastasis, recurrence, and drug resistance in gastric cancer [17].”
BackgroundEmerging Roles for Branched-Chain Amino Acid Metabolism in Cancer
Sivanand, S., & Vander Heiden, M. G. (2020) · Cancer Cell · doi:10.1016/j.ccell.2019.12.011 · Cited by 491 · cited 1×
“Amino Acid Metabolism Abnormalities in amino acid metabolism are common in cancer, but the acquisition and utilization of amino acids varies between different cancers [40].”
BackgroundEmploying Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer
Halbrook, C. J., & Lyssiotis, C. A. (2017) · Cancer Cell · doi:10.1016/j.ccell.2016.12.006 · Cited by 393 · cited 1×
“An obstacle to targeting metabolism for cancer therapy is to determine which specific pathways cancer affects, further deeply resolving aberrant metabolic pathways, and inhibiting the progression of cancer through the understanding of metabolism to discover emerging cancer therapies that are widely studied [47,48].”
BackgroundTargeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364 · cited 1×
“While previous studies have found that the arachidonic acid metabolic pathway plays a pro-carcinogenic role in cancer development [26,27], it is significantly negatively associated with overall gastric cancer risk [18].”
ResultAdenosine Metabolism: Emerging Concepts for Cancer Therapy
Boison, D., & Yegutkin, G. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.007 · Cited by 336 · cited 1×
“An obstacle to targeting metabolism for cancer therapy is to determine which specific pathways cancer affects, further deeply resolving aberrant metabolic pathways, and inhibiting the progression of cancer through the understanding of metabolism to discover emerging cancer therapies that are widely studied [47,48].”
BackgroundLAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers
Pan, J.-H., Zhou, H., Cooper, L., Huang, J.-L., Zhu, S.-B., Zhao, X.-X., Ding, H., Pan, Y.-L., & Rong, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00006 · Cited by 300 · cited 1×
“Targeted therapies have produced encouraging results in the treatment of patients with advanced gastric cancer [4].”
BackgroundSignaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 292
Self-citationChen, D.-L., Ju, H.-Q., Lu, Y.-X., Chen, L.-Z., Zeng, Z.-L., Zhang, D.-S., Luo, H.-Y., Wang, F., Qiu, M.-Z., Wang, D.-S., et al. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0420-1 · Cited by 262 · cited 1×
“Despite significant advancements in the diagnosis and treatment of gastric cancer over the past few decades, the overall survival rate of patients with this disease remains unsatisfactory [3].”
BackgroundSelf-citationExtracellular ATP: A Feasible Target for Cancer Therapy
Vultaggio-Poma, V., Sarti, A. C., & Di Virgilio, F. (2020) · Cells · doi:10.3390/cells9112496 · Cited by 248 · cited 1×
“ATP in the TME has a central role in determining tumor fate and is, therefore, a suitable target for cancer therapy [38].”
BackgroundFatty Acid Oxidation Controls CD8+ Tissue-Resident Memory T-cell Survival in Gastric Adenocarcinoma
Lin, R., Zhang, H., Yuan, Y., He, Q., Zhou, J., Li, S., Sun, Y., Li, D. Y., Qiu, H.-B., Wang, W., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0702 · Cited by 231 · cited 1×
“Trm cells mainly depend on fatty acid oxidation, but deprivation of fatty acids by cancer cells can lead to Trm death [14].”
BackgroundOrnithine and its role in metabolic diseases: An appraisal
Sivashanmugam, M., J., J., V., U., & K.N., S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.024 · Cited by 171 · cited 1×
“Ornithine is a non-essential amino acid involved in the regulation of metabolic disorders, and its depletion is often observed in patients with gastric cancer with lymph nodes and distant metastases [41,42].”
BackgroundTherapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer
Santhanam, S., Alvarado, D. M., & Ciorba, M. A. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.003 · Cited by 105 · cited 1×
“cancer cell motility and impair the anti-tumor response of the immune system, and it is an important mechanism used by cancer to evade immune surveillance [43,44].”
BackgroundRecent Metabolomics Analysis in Tumor Metabolism Reprogramming
Han, J., Li, Q., Chen, Y., & Yang, Y. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.763902 · Cited by 95 · cited 2×
“This enables the development of precision medicine approaches for cancer treatment [11,12].”
BackgroundMetabolomics, metabolic flux analysis and cancer pharmacology
Liang, L., Sun, F., Wang, H., & Hu, Z. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107827 · Cited by 93 · cited 1×
“There is growing evidence that reprogrammed cellular metabolism supports tumorigenesis, progression, metastasis, and drug resistance [5,6].”
BackgroundHuang, S., Guo, Y., Li, Z., Shui, G., Tian, H., Li, B., Kadeerhan, G., Li, Z., Li, X., Zhang, Y., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.14186 · Cited by 91 · cited 2×
“While previous studies have found that the arachidonic acid metabolic pathway plays a pro-carcinogenic role in cancer development [26,27], it is significantly negatively associated with overall gastric cancer risk [18].”
BackgroundResultSelf-citationPathway Analysis for Targeted and Untargeted Metabolomics
Karnovsky, A., & Li, S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0239-3_19 · Cited by 81 · cited 1×
“Bioinformatics analysis can associate metabolites and their corresponding biological functions to understand cancer development and treatment through metabolomics application in cancer metabolic reprogramming [49,50].”
BackgroundEffects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro
Dai, J., Shen, J., Pan, W., Shen, S., & Das, U. N. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-71 · Cited by 76 · cited 1×
“Linoleic acid is the most abundant polyunsaturated fatty acid in human nutrition, and polyunsaturated fatty acids have some tumoricidal effects [25].”
Background5'-Methylthioadenosine and Cancer: old molecules, new understanding
Li, Y., Wang, Y., & Wu, P. (2019) · Journal of Cancer · doi:10.7150/jca.27160 · Cited by 74
Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma
He, L., Chen, J., Xu, F., Li, J., & Li, J. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.09.011 · Cited by 68 · cited 2×
“Owing to their intuitive visual presentation and personalized application, nomograms have become a popular tool for oncology prognosis [7,21].”
BackgroundMethodSelf-citationMi, S., Gong, L., & Sui, Z. (2020) · Journal of Cancer · doi:10.7150/jca.46200 · Cited by 62 · cited 1×
“When uric acidemia is within the normal range, uric acid is thought to scavenge free radicals and contribute to the total antioxidant capacity of plasma [39].”
BackgroundMetabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer
Liang, Q., Wang, C., & Li, B. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1706-z · Cited by 61 · cited 1×
“This enables the development of precision medicine approaches for cancer treatment [11,12].”
BackgroundFujiwara, Y., Kobayashi, T., Chayahara, N., Imamura, Y., Toyoda, M., Kiyota, N., Mukohara, T., Nishiumi, S., Azuma, T., Yoshida, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113259 · Cited by 59 · cited 1×
“However, it has consistently been found to be low in patients with advanced pancreatic cancer malignancy [45].”
BackgroundEmerging metabolomic tools to study cancer metastasis
Melo, L. M. N., Lesner, N. P., Sabatier, M., Ubellacker, J. M., & Tasdogan, A. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.07.003 · Cited by 54 · cited 1×
“It provides valuable information on the metabolic profile of specific tumors and identifies key biomarkers for cancer diagnosis and prognosis [9,10].”
BackgroundMetabolic Reprogramming in Gastric Cancer: Trojan Horse Effect
Bin, Y., Hu, H., Tian, F., Wen, Z., Yang, M., Wu, B.-H., Wang, L., Yao, J., & Li, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.745209 · Cited by 51 · cited 1×
“Tumor metabolic reprogramming includes upregulated aerobic glycolysis, increased glutamine, and lipid accumulation, which support cancer cell development [13].”
BackgroundBednarz‐Misa, I., Fleszar, M. G., Fortuna, P., Lewandowski, Ł., Mierzchała-Pasierb, M., Diakowska, D., & Krzystek‐Korpacka, M. (2021) · Biomolecules · doi:10.3390/biom11081086 · Cited by 46 · cited 1×
“Ornithine is a non-essential amino acid involved in the regulation of metabolic disorders, and its depletion is often observed in patients with gastric cancer with lymph nodes and distant metastases [41,42].”
BackgroundTomasi, M. L., Cossu, C., Spissu, Y., Floris, A., Ryoo, M., Iglesias–Ara, A., Wang, Q., Pandol, S. J., Bhowmick, N. A., Seki, E., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20234 · Cited by 46
Methylthioadenosine (MTA) inhibits melanoma cell proliferation and in vivotumor growth
Andreu-Pérez, P., Hernández‐Losa, J., Moliné, T., Gil, R., Grueso, J., Pujol, A., Cortés, J., Avila, M. A., & Recio, J. A. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-265 · Cited by 36
Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
Long, Z., Zhou, J., Xie, K., Wu, Z., Yin, H., Daria, V., Tian, J., Zhang, N., Li, L., Zhao, Y., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00981 · Cited by 32 · cited 1×
“Nucleotides are key components of DNA and RNA structure, and impairments in their biosynthesis have profound implications for cell physiology and may lead to tumor transformation in cells [32].”
BackgroundAMPK activation by AICAR sensitizes prostate cancer cells to radiotherapy
Rae, C. J., & Mairs, R. J. (2019) · Oncotarget · doi:10.18632/oncotarget.26598 · Cited by 31 · cited 1×
“AICAR may also activate AMP-activated protein kinase (AMPK) to sensitize prostate cancer cells to radiotherapy [36,37].”
BackgroundChen, Y., Chen, Y., Tan, S., Zheng, Y., Liu, S., Zheng, T., Mi, Y., Lin, S., Yang, C., & Li, W. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2186684 · Cited by 30 · cited 1×
“The combined application of immune drugs and targeted drugs in chemotherapy and adjuvant chemotherapy is the current strategy and the future research direction of immunotherapy for GC [16].”
BackgroundNishioka, N., Matsuoka, T., Yashiro, M., Hirakawa, K., Olden, K., & Roberts, J. D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.434 · Cited by 28 · cited 1×
“While previous studies have found that the arachidonic acid metabolic pathway plays a pro-carcinogenic role in cancer development [26,27], it is significantly negatively associated with overall gastric cancer risk [18].”
ResultThe Role of Sphingolipids in Cancer Immunotherapy
Giussani, P., Prinetti, A., & Tringali, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126492 · Cited by 24
Sphingolipids and the link between alcohol and cancer
Barron, K. A., Jeffries, K. A., & Krupenko, N. I. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109058 · Cited by 23
Shen, J., Ye, Y., Chang, D. W., Huang, M., Heymach, J. V., Roth, J. A., Wu, X., & Zhao, H. (2017) · Lung Cancer · doi:10.1016/j.lungcan.2017.10.018 · Cited by 23
Tripathi, V., Jaiswal, P., Assaiya, A., Kumar, J., & Parmar, H. S. (2022) · Current Cancer Drug Targets · doi:10.2174/1568009622666220207101212 · Cited by 21
Pickled Vegetables Intake Impacts the Metabolites for Gastric Cancer
Yang, S., Lv, Y., Wu, C., Liu, B., Shu, Z., & Lin, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s271277 · Cited by 13 · cited 1×
“Participant recruitment, anthropometric measurements, blood sample collection, and other details can be found in the previous study [52,53].”
BackgroundSelf-citationYang, S., Wang, Y., Lyu, Y., Jiang, Y., Xiang, J., Ji, S., Kang, S., Lyu, X., He, C., Li, P., et al. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00269-2 · Cited by 9
Self-citationLu, L., Yu, M., Huang, W., Chen, H., Jiang, G.-F., & Li, G. (2023) · Libyan Journal of Medicine · doi:10.1080/19932820.2023.2220153 · Cited by 7 · cited 1×
“[22] constructed a stomach adenocarcinoma prognostic signature based on anoikis-related lncRNAs and clinical significance.”
BackgroundDi, T., Lai, Y., Luo, Q., Chen, Z., Du, Y., Lin, R., Yang, L., Zhang, L., & Sun, J. P. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03132-6 · Cited by 6 · cited 1×
“[23] developed a novel nomogram integrated with PDL1 and CEA to predict the prognosis of patients with gastric cancer, and the C-index was 0.”
Method
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“A study screening GC survival-associated metabolites identified 24 metabolites by using Kaplan–Meier survival analysis [58].”
MethodZhang, C., Hu, Z., Pan, Z., Ji, Z., Cao, X., Yu, H., Qin, X. Y., & Guan, M. (2024) · The Analyst · doi:10.1039/d3an01723k · Cited by 18
Choi, S. J., Choi, H. S., Kim, H., Lee, J. M., Kim, S. H., Yoon, J. H., Keum, B., Kim, H. J., Chun, H. J., & Park, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179509 · Cited by 13
“Cao et al. recently performed a pathway analysis using plasma metabolites and proposed that purine and arachidonic acid metabolism may play important roles in GC progression [38].”
BackgroundWang, T., & Gao, Y. (2023) · MedComm – Future Medicine · doi:10.1002/mef2.59 · Cited by 7
Exploring the Prognosis-Related Genetic Variation in Gastric Cancer Based on mGWAS
Zhang, Y., Lyu, Y., Chen, L., Cao, K., Chen, J., He, C., Lyu, X., Jiang, Y., Xiang, J., Liu, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015259 · Cited by 5
Self-citation
Metadata
- Authors
- Cao, K., Lyu, Y., Chen, J., He, C., Lyu, X., Zhang, Y., Chen, L., Jiang, Y., Xiang, J., Liu, B., & Wu, C.
- Affiliations
- Fujian Medical University (CN)
- Corresponding author
- Wu, Chuancheng
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2023-08-14
- Volume
- 24
- Issue
- 16
- Pages
- 12774
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC10454100
- OpenAlex
- W4385805803
- Cited by
- 16
- References
- 54
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 5 · 2023: 2
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fujian Natural Science Foundation (2015J01673, 2017J01811)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- gastric cancer, plasma metabolites, prognostic factors, untargeted metabolomics, metabolic signatures, survival prediction, risk scoring, nomogram, purine metabolism, arachidonic acid metabolism, gastric adenocarcinoma
- MeSH terms
- Humans, Prognosis, Quality of Life, Stomach Neoplasms, Nomograms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.